In adults with type 2 diabetes, treatment with tirzepatide 5 mg, 10 mg and 15 mg once weekly was associated with superior weight reduction from baseline compared with placebo, semaglutide 1 mg weekly, titrated insulin degludec, titrated insulin glargine and titrated insulin lispro as an add-on to insulin glargine
Nausea is the most common side effect of GLP-1 medications, reported by 1244% of patients depending on medication and dose level
It ensures the product matches the reference drug in quality and performance
As cardiovascular risk remains high among adults with type 2 diabetes and excess weight, the timely evaluation of new therapies is a public health priority
Anderson and aesthetic specialist Selika Gutierrez-Borst, MS, RN, are introducing a next-generation, physician-led weight loss program that goes beyond prescriptions
Tirzepatide is the active ingredient in Mounjaro, which is also prescribed under the brand name Zepbound for weight management in adults who are overweight or obese